- Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long‐Term Chemotherapy
Nobuhiro Tsuchiya et al, 2020, World Journal of Surgery CrossRef - Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis
Yuko Mataki et al, 2021, Cancers CrossRef - Enhanced mitochondrial co-localization of β-escin micelle and pancreatic tumor accumulation relation
Burcu Uner et al, 2023, Journal of Drug Delivery Science and Technology CrossRef - Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy
Advait Shetty et al, 2020, ACS Omega CrossRef - Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
Hiroaki Yanagimoto et al, 2020, Cancers CrossRef - Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer “in a Korean” population: A single-center cohort study
In Rae Cho et al, 2017, Seminars in Oncology CrossRef - Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab‑paclitaxel chemotherapy: A case report
Tetsuo Yokota et al, 2019, Molecular and Clinical Oncology CrossRef - Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained co-delivery of gemcitabine and paclitaxel to pancreatic cancer cells
Ahmed M. Shabana et al, 2021, International Journal of Pharmaceutics CrossRef - Conversion surgery with gemcitabine plus nab‑paclitaxel for locally advanced unresectable pancreatic cancer: A case report
Ryosuke Okura et al, 2018, Molecular and Clinical Oncology CrossRef - Currently available first-line drug therapies for treating pancreatic cancer
Jennifer L. Olson et al, 2018, Expert Opinion on Pharmacotherapy CrossRef - Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis
Hiroki Irie et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef - Advances of pathological complete response after neoadjuvant therapy for pancreatic cancer
Lingdi Yin et al, 2019, Journal of Pancreatology CrossRef - Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Heng‐Chung Kung et al, 2023, MedComm CrossRef - Factors affecting response variables with emphasis on drug release and loading for optimization of liposomes
Shantanu Pande, 2024, Artificial Cells, Nanomedicine, and Biotechnology CrossRef - Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded favorably to nonsurgical treatment
Toshimichi Asano et al, 2018, Journal of Hepato-Biliary-Pancreatic Sciences CrossRef - Context Matters—Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer
Sushmitha Sankarasubramanian et al, 2021, Frontiers in Cell and Developmental Biology CrossRef - A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine
Masahide Hiyoshi et al, 2017, Clinical Journal of Gastroenterology CrossRef - Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
Fabiana Napolitano et al, 2019, Cancers CrossRef - The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registry
L.J.H. Brada et al, 2021, Pancreatology CrossRef - Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
Anita Thyagarajan et al, 2019, Cancers CrossRef - A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
Christian Chapa-González et al, 2022, Life CrossRef - Current trends and issues of conversion surgery for patients with locally advanced unresectable pancreatic cancer
Toshimichi ASANO et al, 2018, Suizo CrossRef